Skip to content

Clinical trials

Musculoskeletal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Country / region: United States Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20053
20061
20071
20082
20098
20101
20115
20124
20138
201414
201510
201610
201720
201817
201915
202016
202112
202219
202313
202413
202512
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123
Recruiting27
Terminated26
Active, not recruiting15
Unknown status15
Enrolling by invitation9
Withdrawn6
Not yet recruiting3
Suspended1
No longer available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
QED Therapeutics, a BridgeBio company8
BioMarin Pharmaceutical7
University of Pittsburgh7
VA Office of Research and Development6
University of Texas at Austin4
Catabasis Pharmaceuticals3
Emory University3
Fulcrum Therapeutics3
Longevity Metrics, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases227
Joint Diseases48
Arthritis42
Bone Diseases37
Genetic Diseases, Inborn30
Osteoarthritis28
Muscular Diseases27
Rheumatic Diseases26
Nervous System Diseases25
Neuromuscular Diseases25

Trials

Showing 1 to 25 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.